Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 4 Buy, 3 Hold, 1 Sell.
BMYMP Analyst Ratings
Buy
8
Ratings
4 Buy
3 Hold
1 Sell
Based on 8 analysts giving stock ratings to Bristol-Myers Squibb Company PFD CONV 2 in the past 3 months
